1. Coronavirus disease 2019 (COVID-19) and obesity. Impact of obesity and its main comorbidities in the evolution of the disease
- Author
-
Susana Jiménez-Murcia, Francisco J. Tinahones, Lucero Munguía, Rebeca Barahona San Millan, José M Fernández Real, José Carlos Fernández-García, Fernando Fernández-Aranda, Ana María Gómez-Pérez, Amanda Jiménez, Ana de Hollanda, Emilio Ortega, Isabel Cornejo-Pareja, and Alexandre Aguilera Luque
- Subjects
medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,business.industry ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,COVID-19 ,Disease ,Comorbidity ,medicine.disease ,Prognosis ,Obesity ,Psychiatry and Mental health ,Clinical Psychology ,Eating disorders ,Blood pressure ,Risk Factors ,Diabetes mellitus ,Pandemic ,Hypertension ,medicine ,Diabetes Mellitus ,Humans ,Intensive care medicine ,business ,Randomized Controlled Trials as Topic - Abstract
The COVID-19 pandemic is posing a great challenge worldwide. Its rapid progression has caused thousands of deaths worldwide. Although multiple aspects remain to be clarified, some risk factors associated with a worse prognosis have been identified. These include obesity and some of its main complications, such as diabetes and high blood pressure. Furthermore, although the possible long-term complications and psychological effects that may appear in survivors of COVID-19 are not well known yet, there is a concern that those complications may be greater in obese patients. In this manuscript, we review some of the data published so far and the main points that remain to be elucidated are emphasized.
- Published
- 2020